Therapeutic Implications of the Microbial Hypothesis of Mental Illness.
Savitz, Jonathan, Yolken, Robert H · Current topics in behavioral neurosciences · 2023 · DOI
Quick Summary
This review examines whether certain germs—especially viruses like EBV and CMV, and parasites—might contribute to mental illness and ME/CFS. Researchers looked at studies testing whether anti-viral and anti-parasite medications could help treat these conditions, and also explored whether changes in gut bacteria might play a role. The authors found some evidence supporting these connections, though much more research is needed to understand how they work.
Why It Matters
ME/CFS patients often experience concurrent psychiatric symptoms and have abnormal immune responses; understanding whether microbes trigger or worsen these symptoms could lead to new targeted treatments. This review consolidates evidence specifically examining antiviral and microbiome-based therapies for ME/CFS, providing context for potential future clinical applications in this severely understudied population.
Observed Findings
Some clinical trials of anti-herpes medications showed improvements in inflammatory markers and outcomes in certain medical and psychiatric conditions.
Gut dysbiosis (altered bacterial composition) has been documented in psychiatric disorders and potentially in ME/CFS.
Several randomized controlled trials of probiotics showed modest effects on psychiatric symptoms in schizophrenia, bipolar disorder, and major depressive disorder.
Neurotrophic herpesviruses and Toxoplasma gondii show epidemiological associations with psychiatric illness in subsets of populations.
The evidence base for antiviral/antiparasitic treatment in ME/CFS remains limited compared to psychiatric disorders.
Inferred Conclusions
Microorganisms may contribute to psychiatric symptoms and ME/CFS in genetically or immunologically predisposed individuals, warranting further investigation.
Microbiome-targeted interventions (probiotics, antivirals) show potential therapeutic promise but require larger, more rigorous trials in disease-specific populations.
A subset of psychiatric and post-viral illnesses may have infectious or dysbiotic underpinnings that differ from primary psychiatric conditions, suggesting heterogeneous pathophysiology.
Remaining Questions
Which patients with ME/CFS carry pathogenic microbes and which therapeutic approaches work best for specific microbial subtypes?
What This Study Does Not Prove
This umbrella review does not establish causation—it identifies associations and mechanistic plausibility. The heterogeneity of included trials and inconsistent findings across studies mean individual antimicrobial therapies have not yet been proven effective for ME/CFS specifically. Correlation between microbes and illness does not prove the microbes caused the illness.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.